Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load

INTRODUCTION: A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors. However, data on use of this combination as a strategy of switch are limited. Aims of the study were to assess the long-term efficacy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Galizzi, Nadia, Galli, Laura, Poli, Andrea, Gianotti, Nicola, Carini, Elisabetta, Bigoloni, Alba, Tambussi, Giuseppe, Nozza, Silvia, Lazzarin, Adriano, Castagna, Antonella, Mancusi, Daniela, Termini, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815573/
https://www.ncbi.nlm.nih.gov/pubmed/29451870
http://dx.doi.org/10.1371/journal.pone.0191300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815573/
https://www.ncbi.nlm.nih.gov/pubmed/29451870
http://dx.doi.org/10.1371/journal.pone.0191300

Ejemplares similares